December 6th Grifols Congressional Briefing: The Importance of Plasma Therapies In Treating Rare Diseases

Grofols cordially invites Members and Staff to attend a Congressional Luncheon Briefing on:  The Importance of Plasma Therapies In Treating Rare Diseases
Thursday, December 6th, 2012
2360 Rayburn House Office Building

12:00pm – 1:15pm
Lunch Will Be Served

Please join them for this discussion of plasma therapies and the unique role they play in the treatment of rare, life-threatening diseases such as hemophilia, immune deficiencies, genetic emphysema, and chronic inflammatory demyelinating polyneuropathy.

– Linda Hasting, Plasma Donor, Littleton, Colorado
– Mary J. Kuhn, President, Grifols North American Manufacturing Operations
– Jim Crone, Chronic Inflammatory Demylenating Polyneuropathy Patient Advocate, Peoria, Illinois

Please RSVP to Mallory O’Connor at or 202-293-1506

Established in 1940, Grifols is a global healthcare company that produces plasma medicines used to treat patients in more than 90 countries around the world.

* This briefing complies with the requirements of the widely attended event exception.